Switching to virtual trials requires more than just running standard methods in front of a webcam. Your entire clinical approach must be reconceptualized to get the most benefit from a virtual approach. That’s why you cannot afford to miss the 5th Virtual Clinical Trials conference – the industry’s leading, longest-lasting conference on this subject, offering...
Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network's networking platform. Connect with life science colleagues from all over the world. BioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life...
We are very excited to announce “BVS’ Biotech Holiday Celebration" in Malden. We were able to secure a wonderful hip location indoors at 21 Pleasant Street in Malden, which is only 5.4 miles from Cambridge. We will also be offering a shuttle if folks need transportation and it is a quick trip on the Orange...
10am PT Join us for our next Conversation with Thought Leaders as we focus on California as a medtech stronghold. This panel of thought leaders, including CEOs from the Medtech Innovator portfolio, will discuss trends, challenges and opportunities in this frothy market and insights on how they stay ahead of the curve. Paul Grand will...
Date: December 16, 2021 Time: 4:30 - 6:30 PM Location: LSPA Offices, 650 E. Swedesford Road, Wayne, Pa 19087 Important Note: Proof of Vaccination is REQUIRED. Please be prepared to provide a physical copy or photo of your vaccination card upon arrival. Our Holiday Mixer Hosted By LSPA Board of Directors is a time to celebrate the year's...
Companies sponsoring a clinical trial often discuss Diversity, Equity, and Inclusion (DE&I) efforts to achieve better outcomes for their patients and their trial, but those discussions don’t often translate into the design. As an industry, it's time to put our money where our mouth is and implement DE&I efforts into trial designs. Including underserved populations...
Big4Bio, the leading news aggregator service for the top biotech hubs in the United States, proudly announces the publishing of the 6th edition of On Your Mark, a compendium of virtual investor and partnering events revolving around the 40th Annual J.P. Morgan Healthcare Conference (#JPM2022). As J.P. Morgan has recently decided to go virtual, many...
Join us virtually on January 9th as we examine the revolution in digital orthopedics in the age of big data.
BIOTECH SHOWCASE GOES 100% VIRTUAL! The health and safety of our sponsors, speakers, presenting companies, our extensive network of supporters and all delegates as well as our staff is of utmost importance and given the ongoing developments with the COVID-19 pandemic, we have made this tough but important decision to transition Biotech Showcase into a fully...
This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. The J.P. Morgan 40th Annual Healthcare Conference will take place 10-13 January 2022 in a virtual format.
The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital...
The 17th Annual Non-Dilutive Funding Summit brings together funding program directors at HSS (BARDA), DOD (CDMRP), NIH (NCI, NIAID, NINDS, NIDDK), and CIRM with hundreds of life science industry executives in order to work toward the shared purpose of commercializing novel solutions in biotech, medtech, healthtech, etc. NDFS is an educational event with government officials as keynote speakers, so...
